The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which ...
AUCKLAND, New Zealand--(BUSINESS WIRE)--A new retrospective study of real-world data (‘RWD’) has shown significantly improved wound closure times for diabetic foot ulcers (‘DFU’) and much greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results